HOW BIOTECH & PHARMA COMPANIES USE … · Title: COLL-1708 0417 Biotech and Pharma Solution...
Transcript of HOW BIOTECH & PHARMA COMPANIES USE … · Title: COLL-1708 0417 Biotech and Pharma Solution...
https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-lshc-2016-life-sciences-outlook.pdf
https://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069962.htm
https://www.zs.com/about/news-and-events/as-doctors-keep-closing-doors-on-pharma-reps.aspx
SOLUTIONSPROBLEMS
MicroStrategy mobile apps help commercial
sales reps tailor their interactions with physicians
so they can make the most e�ective use of
limited meeting times.
MicroStrategy solutions help pharma executives
optimize their supply chain, marketing, and sales
operations in order to maximize the returns on new
product o�erings.
MicroStrategy security solutions help life
sciences companies protect intellectual property and
sensitive clinical data using sophisticated physical and
logical access controls.
MicroStrategy helps drug companies monitor
and analyze their complex global distribution networks
to surface hidden performance issues and uncover
potential counterfeiting situations.
MicroStrategy helps marketing executives
gauge the e�ectiveness of advertising campaigns
by analyzing their in�uence on drug purchases and
prescription renewals.
TASKS
EXECUTIVEDASHBOARD
MARKETINGPERFORMANCE
DIGITALEMPLOYEE
BADGE
DISTRIBUTIONANALYSIS
FIELD SALESENABLEMENT
Leading biotech and pharmaceutical companies rely on MicroStrategy solutions to bring new products to market faster and to maximize the return on their development investments. Learn more at microstrategy.com/solutions/biotechandpharma
Operating in intensely competitive global markets, life sciences companies need powerful analytical
solutions to accelerate drug development and optimize marketing and sales activities.
HOW BIOTECH & PHARMA COMPANIES USE ANALYTICS TO BRINGINSIGHT AND EFFICIENCY TO EVERY ASPECT OF THEIR VALUE CHAINS
https://www.statnews.com/2016/03/09/drug-industry-advertising/
IN THE US, PHARMA COMPANIES
RECEIVE A
5-YEAR PERIODOF
MARKET EXCLUSIVITY FOR NEWLY APPROVED
DRUGS
Drug makers spent$5.2 BILLION
on TV and print advertising in 2015
In 2011, the UK’s life sciences and
health care industry su�ered
$2.9 billion in losses due
to IP theft.
http://trade.gov/topmarkets/pdf/Pharmaceuticals_Executive_Summary.pdf
The size of the global counterfeit drug market is estimated to be as high as $200 billion, and can make up
of all drugs sold in some countries.
44% of physicians are considered “accessible” to sales reps.
Based on a 2016 study, just
1/2